EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Innate Immunity in Cancer Biology and Therapy

Yuxia Zhang, Wenjing Xue, Caili Xu, Yanyang Nan, Shuang Mei, Dianwen Ju, Shaofei Wang, Xuyao Zhang iD

International Journal of Molecular Sciences · 08.07.2023 · 24 (14) · 11233

DOI: 10.3390/ijms241411233 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.07.2023. Verfasst von Yuxia Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 20120…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Sailing Program, Scientific and Innovative Action Plan of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapies including adaptive immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T cells, have developed the treatment of cancer in clinic, and most of them focus on activating T cell immunity. Although these strategies have obtained unprecedented clinical responses, only limited subsets of cancer patients could receive long-term benefits, highlighting the demand for identifying novel targets for the new era of tumor immunotherapy. Innate immunity has been demonstrated to play a determinative role in the tumor microenvironment (TME) and influence the clinical outcomes of tumor patients. A thorough comprehension of the innate immune cells that infiltrate tumors would allow for the development of new therapeutics. In this review, we outline the role and mechanism of innate immunity in TME. Moreover, we discuss innate immunity-based cancer immunotherapy in basic and clinical studies. Finally, we summarize the challenges in sufficiently motivating innate immune responses and the corresponding strategies and measures to improve anti-tumor efficacy. This review could aid the comprehension of innate immunity and inspire the creation of brand-new immunotherapies for the treatment of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansImmunity, InnateImmunotherapyT-LymphocytesBiologyTumor Microenvironment

Stichwörter der Autor:innen

cancer therapychimeric antigen receptorscytokinesimmune checkpoint inhibitorsinnate immunity

Autor:innen und Institutionen

  • Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, China.
  • Shanghai Tinova Immune Therapeutics Co., Ltd., Shanghai 201413, China.
  • Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.

ORCID-Profile: Xuyao Zhang

Förderung

  • National Natural Science Foundation of China
  • Shanghai Sailing Program
  • Scientific and Innovative Action Plan of Shanghai

Zitieren

APA

Zhang, Y., Xue, W., Xu, C., Nan, Y., Mei, S., Ju, D., Wang, S., & Zhang, X. (2023). Innate Immunity in Cancer Biology and Therapy. International Journal of Molecular Sciences, 24(14), 11233. https://doi.org/10.3390/ijms241411233

Vancouver

Zhang Y, Xue W, Xu C, Nan Y, Mei S, Ju D, et al. Innate Immunity in Cancer Biology and Therapy. International Journal of Molecular Sciences. 2023;24(14):11233. doi:10.3390/ijms241411233

BibTeX
@article{Zhang2023,
  author = {Zhang, Yuxia and Xue, Wenjing and Xu, Caili and Nan, Yanyang and Mei, Shuang and Ju, Dianwen and Wang, Shaofei and Zhang, Xuyao},
  title = {Innate Immunity in Cancer Biology and Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {14},
  pages = {11233},
  doi = {10.3390/ijms241411233}
}
Kostenlos starten →